Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
134.3 USD | -0.86% | +4.53% | -2.63% |
25/04 | Labcorp beats quarterly estimates on strong testing demand | RE |
24/04 | Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155 | MT |
Chart calendar Quest Diagnostics Incorporated
Upcoming events on Quest Diagnostics Incorporated
Past events on Quest Diagnostics Incorporated
23/04/2024 06:00 pm | Q1 2024 Earnings Call |
23/04/2024 04:15 pm | Q1 2024 Earnings Release |
05/04/2024 | Ex-dividend day |
13/03/2024 07:45 pm | Barclays Global Healthcare Conference |
01/02/2024 07:00 pm | Q4 2023 Earnings Call |
01/02/2024 05:15 pm | Q4 2023 Earnings Release |
16/01/2024 | Ex-dividend day |
10/01/2024 05:15 am | JPMorgan Healthcare Conference |
24/10/2023 06:00 pm | Q3 2023 Earnings Call |
24/10/2023 04:15 pm | Q3 2023 Earnings Release |
05/10/2023 | Ex-dividend day |
13/09/2023 11:30 pm | Baird Global Healthcare Conference |
26/07/2023 06:00 pm | Q2 2023 Earnings Call |
26/07/2023 04:15 pm | Q2 2023 Earnings Release |
10/07/2023 | Ex-dividend day |
09/06/2023 12:00 am | Jefferies Global Healthcare Conference |
07/06/2023 01:50 am | William Blair Growth Stock Conference |
23/05/2023 | National Drug & Alcohol Screening Association Conference |
17/05/2023 08:00 pm | Annual General Meeting |
27/04/2023 06:00 pm | Q1 2023 Earnings Call |
Past dividends on Quest Diagnostics Incorporated
05/04/2024 | Quarterly 0.75 USD |
16/01/2024 | Quarterly 0.71 USD |
05/10/2023 | Quarterly 0.71 USD |
10/07/2023 | Quarterly 0.71 USD |
06/04/2023 | Quarterly 0.71 USD |
17/01/2023 | Quarterly 0.66 USD |
03/10/2022 | Quarterly 0.66 USD |
05/07/2022 | Quarterly 0.66 USD |
05/04/2022 | Quarterly 0.66 USD |
18/01/2022 | Quarterly 0.62 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7 726 7 717 0.11% | 9 437 9 358 0.84% | 10 788 10 697 0.85% | 9 883 9 828 0.56% | 9 252 9 214 0.41% | 9 448 |
EBITDA Million USD | Released Forecast Spread | 1 549 1 547 0.14% | 2 468 2 369 4.19% | 2 870 2 864 0.2% | 2 059 2 081 -1.04% | 1 788 1 860 -3.87% | 1 885 |
EBIT Million USD | Released Forecast Spread | 1 220 1 199 1.79% | 2 107 1 960 7.48% | 2 462 2 417 1.87% | 1 742 1 753 -0.61% | 1 457 1 494 -2.44% | 1 515 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 076 964 11.6% | 1 884 1 793 5.09% | 2 599 2 514 3.4% | 1 235 1 455 -15.14% | 1 130 1 174 -3.74% | 1 206 |
Net income Million USD | Released Forecast Spread | 858 773 10.97% | 1 431 1 382 3.52% | 1 995 1 869 6.75% | 946 1 054 -10.28% | 854 876 -2.56% | 894 |
EPS USD | Released Forecast Spread | 6,28 5,61 11.96% | 10,5 10,3 1.73% | 15,6 15,0 3.92% | 7,97 8,76 -8.97% | 7,49 7,67 -2.38% | 7,82 |
Announcement Date | 30/01/20 | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 611 2 639 -1.05% | 2 453 2 336 5.02% | 2 486 2 343 6.09% | 2 333 2 258 3.31% | 2 331 2 203 5.83% | 2 338 2 258 3.55% | 2 295 2 268 1.19% | 2 288 2 251 1.63% | 2 366 2 287 3.47% | 2 395 | 2 365 | 2 330 | 2 426 | 2 479 |
EBITDA Million USD | Released Forecast Spread | 660 622 6.11% | 515 483 6.63% | 504 470 7.13% | 407 425 -4.31% | 431 413 4.3% | 473 466 1.42% | 464 464 -0.05% | 420 479 -12.28% | 436 415 5.04% | 487 | 484 | 463 | 460 | 505 |
EBIT Million USD | Released Forecast Spread | 554 530 4.46% | 435 391 11.17% | 423 394 7.41% | 330 352 -6.19% | 350 335 4.54% | 389 381 2.18% | 380 382 -0.43% | 338 373 -9.26% | 349 331 5.29% | 405 | 398 | 365 | 373 | 430 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 452 472 -4.24% | 323 353 -8.46% | 351 345 1.73% | 109 324 -66.32% | 277 337 -17.9% | 317 342 -7.42% | 299 333 -10.21% | 237 306 -22.55% | 266 255 4.45% | 325 | 319 | 285 | 280 | 345 |
Net income Million USD | Released Forecast Spread | 355 363 -2.14% | 234 250 -6.4% | 256 236 8.51% | 101 195 -48.16% | 202 186 8.48% | 235 229 2.63% | 225 225 0.21% | 192 210 -8.62% | 194 181 7.01% | 238 | 233 | 207 | 207 | 253 |
EPS USD | Released Forecast Spread | 2,92 2,90 0.85% | 1,96 2,04 -3.72% | 2,17 1,96 10.85% | 0,87 1,63 -46.71% | 1,78 1,60 11.46% | 2,05 2,00 2.64% | 1,96 1,94 0.84% | 1,70 1,85 -7.9% | 1,72 1,60 7.48% | 2,08 | 2,06 | 1,83 | 1,86 | 2,28 |
Announcement Date | 21/04/22 | 21/07/22 | 20/10/22 | 02/02/23 | 27/04/23 | 26/07/23 | 24/10/23 | 01/02/24 | 23/04/24 | - | - | - | - | - |
Past sector events for Quest Diagnostics Incorporated
26/04/2024 05:00 pm | HCA HEALTHCARE, INC.: Q1 2024 Earnings Release |
26/04/2024 04:58 pm | PT MEDIKALOKA HERMINA TBK: Q1 2024 Earnings Release |
26/04/2024 11:15 am | MEDICOVER AB: Q1 2024 Earnings Release |
26/04/2024 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q1 2024 Earnings Release |
26/04/2024 01:33 am | ACCOLADE, INC.: Q4 2024 Earnings Release |
25/04/2024 04:28 pm | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
25/04/2024 06:39 am | BUMRUNGRAD HOSPITAL: Q1 2024 Earnings Release |
25/04/2024 | MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
25/04/2024 01:46 am | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
25/04/2024 01:45 am | CHEMED CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DGX Stock
- Calendar Quest Diagnostics Incorporated